• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡罗昔康

Piroxicam.

作者信息

Mostafa Gamal A E, Al-Dosseri Abdullah S, Al-Badr Abdullah A

机构信息

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

出版信息

Profiles Drug Subst Excip Relat Methodol. 2020;45:199-474. doi: 10.1016/bs.podrm.2019.10.007. Epub 2019 Dec 18.

DOI:10.1016/bs.podrm.2019.10.007
PMID:32164968
Abstract

A comprehensive profile of piroxicam including the nomenclatures, formulae, elemental composition, appearance, uses and applications. The methods which were utilized for the preparation of the drug substance and their respective schemes are outlined. The physical characteristics of the drug including the ionization constant, solubility, x-ray powder diffraction pattern, differential scanning calorimetry, thermal behavior and spectroscopic studies are described. The methods which were used for the analysis of the drug substance in bulk drug and/or in pharmaceutical formulations including the compendial, spectrophotometric, electrochemical and the chromatographic methods are reported. The stability, toxicity, pharmacokinetics, bioavailability, drug evaluation, comparison, in addition to compiled reviews on the drug substance are involved. Finally, more than four hundred and fifty references are listed at the end of this profile.

摘要

吡罗昔康的全面概述,包括命名法、分子式、元素组成、外观、用途及应用。概述了用于制备原料药的方法及其各自的方案。描述了该药物的物理特性,包括电离常数、溶解度、X射线粉末衍射图谱、差示扫描量热法、热行为和光谱研究。报告了用于分析原料药及/或药物制剂中药物的方法,包括药典法、分光光度法、电化学法和色谱法。还涉及该原料药的稳定性、毒性、药代动力学、生物利用度、药物评价、比较以及汇编综述。最后,本概述末尾列出了四百五十多篇参考文献。

相似文献

1
Piroxicam.吡罗昔康
Profiles Drug Subst Excip Relat Methodol. 2020;45:199-474. doi: 10.1016/bs.podrm.2019.10.007. Epub 2019 Dec 18.
2
Danazol.达那唑
Profiles Drug Subst Excip Relat Methodol. 2022;47:149-326. doi: 10.1016/bs.podrm.2021.10.005. Epub 2021 Dec 23.
3
Cefpodoxime proxetil.头孢泊肟酯
Profiles Drug Subst Excip Relat Methodol. 2019;44:1-165. doi: 10.1016/bs.podrm.2019.02.001. Epub 2019 Apr 16.
4
Ganciclovir.更昔洛韦
Profiles Drug Subst Excip Relat Methodol. 2018;43:1-208. doi: 10.1016/bs.podrm.2017.12.001. Epub 2018 Mar 19.
5
Azilsartan medoxomil.阿齐沙坦美多昔酯
Profiles Drug Subst Excip Relat Methodol. 2020;45:1-39. doi: 10.1016/bs.podrm.2019.10.001. Epub 2019 Dec 6.
6
Lapatinib: A comprehensive profile.拉帕替尼:全面剖析。
Profiles Drug Subst Excip Relat Methodol. 2023;48:135-166. doi: 10.1016/bs.podrm.2022.11.005. Epub 2022 Dec 26.
7
Pravastatin sodium.普伐他汀钠
Profiles Drug Subst Excip Relat Methodol. 2014;39:433-513. doi: 10.1016/B978-0-12-800173-8.00008-8.
8
Glutathione.谷胱甘肽
Profiles Drug Subst Excip Relat Methodol. 2015;40:43-158. doi: 10.1016/bs.podrm.2015.02.001. Epub 2015 Mar 31.
9
Bisoprolol: A comprehensive profile.比索洛尔:全面剖析。
Profiles Drug Subst Excip Relat Methodol. 2021;46:51-89. doi: 10.1016/bs.podrm.2020.07.006. Epub 2020 Sep 8.
10
Cefdinir.
Profiles Drug Subst Excip Relat Methodol. 2014;39:41-112. doi: 10.1016/B978-0-12-800173-8.00002-7.

引用本文的文献

1
Repurposing of Drug Candidates for Treatment of Skin Cancer.用于治疗皮肤癌的候选药物的重新利用。
Front Oncol. 2021 Jan 8;10:605714. doi: 10.3389/fonc.2020.605714. eCollection 2020.